journal article·2014-01

The behavior of cardiac progenitor cells on macroporous pericardium-derived scaffolds

Sareh Rajabi-Zeleti, Sasan Jalili-Firoozinezhad, Mahnaz Azarnia, Fahimeh Khayyatan, Sadaf Vahdat, Saman Nikeghbalian, Ali Khademhosseini, Hossein Baharvand, Nasser Aghdami

Biomaterials· Volume 35· Issue 3
Publisher page

Abstract

Cardiovascular diseases hold the highest mortality rate among other illnesses which reveals the significance of current limitations in common therapies. Three-dimensional (3D) scaffolds have been utilized as potential therapies for treating heart failure following myocardial infarction (MI). In particular, native tissues have numerous properties that make them potentially useful scaffolding materials for recreating the native cardiac extracellular matrix (ECM). Here, we have developed a pericardium-derived scaffold that mimics the natural myocardial extracellular environment and investigated its properties for cardiac tissue engineering. Human pericardium membranes (PMs) were decellularized to yield 3D macroporous pericardium scaffolds (PSs) with well-defined architecture and interconnected pores. PSs enabled human Sca-1(+) cardiac progenitor cells (CPCs) to migrate, survive, proliferate and differentiate at higher rates compared with decellularized pericardium membranes (DPMs) and collagen scaffolds (COLs). Interestingly, histological examination of subcutaneous transplanted scaffolds after one month revealed low immunological response, enhanced angiogenesis and cardiomyocyte differentiation in PSs compared to DPMs and COLs. This research demonstrates the feasibility of fabricating 3D porous scaffolds from native ECMs and suggests the therapeutic potential of CPC-seeded PSs in the treatment of ischemic heart diseases.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
1. Heart disease and stroke statistics-2011 update: a report from the American Heart Association
2. Heart regeneration10.1038/nature10147 ↗
3. Bioengineering heart muscle: a paradigm for regenerative medicine10.1146/annurev-bioeng-071910-124701 ↗
4. Generation of tissue constructs for cardiovascular regenerative medicine: from cell procurement to scaffold design10.1016/j.biotechadv.2012.08.006 ↗
5. Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium10.1016/j.biomaterials.2012.04.028 ↗
6. Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts10.1016/j.biomaterials.2007.07.022 ↗
7. Substrates for cardiovascular tissue engineering10.1016/j.addr.2011.01.007 ↗
8. Development of a porcine bladder acellular matrix with well-preserved extracellular bioactive factors for tissue engineering10.1089/ten.tec.2009.0311 ↗
9. Decellularized porcine brain matrix for cell culture and tissue engineering scaffolds10.1089/ten.tea.2010.0724 ↗
10. Tissue decellularization by activation of programmed cell death10.1016/j.biomaterials.2013.04.058 ↗
11. Engineered whole organs and complex tissues10.1016/S0140-6736(12)60073-7 ↗
12. Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering10.1016/j.biomaterials.2013.03.054 ↗
13. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart10.1038/nm1684 ↗
14. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds10.1146/annurev-bioeng-071910-124743 ↗
15. Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair10.1016/j.biomaterials.2010.06.056 ↗
16. Extracellular matrix scaffold for cardiac repair10.1161/CIRCULATIONAHA.104.525436 ↗
17. Patient-to-patient variability in autologous pericardial matrix scaffolds for cardiac repair10.1007/s12265-011-9293-z ↗
18. Extracellular matrix, mechanotransduction and structural hierarchies in heart tissue engineering10.1098/rstb.2007.2114 ↗
19. RGD-modified acellular bovine pericardium as a bioprosthetic scaffold for tissue engineering10.1007/s10856-009-3791-4 ↗
20. Porous acellular bovine pericardia seeded with mesenchymal stem cells as a patch to repair a myocardial defect in a syngeneic rat model10.1016/j.biomaterials.2006.06.022 ↗
21. Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering10.1089/ten.tea.2009.0768 ↗
22. Biomimetic materials for tissue engineering10.1016/j.addr.2007.08.041 ↗
23. Vascularization in tissue engineering10.1016/j.tibtech.2008.04.009 ↗
24. The role of the sca-1+/CD31-cardiac progenitor cell population in postinfarction left ventricular remodeling10.1634/stemcells.2005-0386 ↗
25. Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy10.1007/BF03086138 ↗
26. Adult cardiac stem cells are multipotent and support myocardial regeneration10.1016/S0092-8674(03)00687-1 ↗
27. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function10.1073/pnas.0502678102 ↗
28. Preparation of ready-to-use, storable and reconstituted type I collagen from rat tail tendon for tissue engineering applications10.1038/nprot.2006.430 ↗
29. First steps towards tissue engineering of small-diameter blood vessels: preparation of flat scaffolds of collagen and elastin by means of freeze drying10.1002/jbm.b.30444 ↗
30. Average protein density is a molecular-weight-dependent function10.1110/ps.04688204 ↗
31. Fast and sensitive colloidal coomassie G-250 staining for proteins in polyacrylamide gels
32. Standards and guidelines for biopolymers in tissue-engineered medical products: ASTM alginate and chitosan standard guides. American Society for Testing and Materials10.1111/j.1749-6632.2001.tb03850.x ↗
33. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology10.1038/nprot.2008.229 ↗
34. Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors and transplantation in a rat model of optic chiasm demyelination10.1371/journal.pone.0027925 ↗
35. Complexity in biomaterials for tissue engineering10.1038/nmat2441 ↗
36. Carbodiimide cross-linked amniotic membranes for cultivation of limbal epithelial cells10.1016/j.biomaterials.2010.05.034 ↗
37. Type II collagen-hyaluronan hydrogel–a step towards a scaffold for intervertebral disc tissue engineering10.22203/eCM.v020a12 ↗
38. Fabrication of porous chitosan scaffolds for soft tissue engineering using dense gas CO210.1016/j.actbio.2010.11.043 ↗
39. Engineered cell-laden human protein-based elastomer10.1016/j.biomaterials.2013.03.076 ↗
40. Nanowired three-dimensional cardiac patches10.1038/nnano.2011.160 ↗
41. Mechanical properties of human pericardium. Differences in viscoelastic response when compared with canine pericardium10.1161/01.RES.57.3.475 ↗
42. Decellularization of pericardial tissue and its impact on tensile viscoelasticity and glycosaminoglycan content10.1016/j.actbio.2010.11.017 ↗
43. Histologic Characteristics and mechanical properties of bovine pericardium treated with decellularization and alpha-galactosidase: a comparative study10.5090/kjtcs.2012.45.6.368 ↗
44. Biomaterial strategies for alleviation of myocardial infarction10.1098/rsif.2011.0301 ↗
45. Structural and biomechanical characterizations of porcine myocardial extracellular matrix10.1007/s10856-012-4660-0 ↗
46. Biomimetic acellular detoxified glutaraldehyde cross-linked bovine pericardium for tissue engineering10.1016/j.msec.2012.12.062 ↗
47. Three-dimensional biomaterials for the study of human pluripotent stem cells10.1038/nmeth.1671 ↗
48. Matrix elasticity directs stem cell lineage specification10.1016/j.cell.2006.06.044 ↗
49. A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro10.1016/j.actbio.2012.07.033 ↗